Panagiotis Anagnostis

MD

Medical School, Aristotle University of Thessaloniki, Thessaloniki

Professional interests: neuroendocrinology, endocrinology of metabolism, adrenal disorders, endocrine hypertension, diabetes mellitus, lipid disorders, osteoporosis, menopause, thyroid disease

 

Scopus Profile: link

ID ORCID: 0000-0002-8949-4312

Google Scholar: ссылка

 

Latest articles in Scopus:

Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactation-Associated Osteoporosis: A Systematic Review and Meta-analysis
Anagnostis, P., Lampropoulou-Adamidou, K., Bosdou, J.K., ...Goulis, D.G., Tournis, S.
The Journal of clinical endocrinology and metabolism, 2024, 109(3), 879–901

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
Dharmayat, K.I., Vallejo-Vaz, A.J., Stevens, C.A.T., ...Santos, R., Ray, K.K.
The Lancet, 2024, 403(10421), 55–66

Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Herman, R., Janez, A., Mikhailidis, D.P., ...Antignani, P.L., Jensterle, M.
Current Vascular Pharmacology, 2024, 22(1), 28–35

Thyroid Disorders and Peripheral Arterial Disease
Studen, K.B., Gaberscek, S., Zaletel, K., ...Mikhailidis, D.P., Poredos, P.
Current Vascular Pharmacology, 2024, 22(1), 36–40

Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry
Barkas, F., Rizos, C.V., Liamis, G., ...Boutari, C., Liberopoulos, E.
Journal of Clinical Lipidology, 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry
Antza, C., Rizos, C.V., Kotsis, V., ...Milionis, H., Liberopoulos, E.
Biomedicines, 2024, 12(1), 231

Antiosteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review
Anagnostis, P., Divaris, E., Bosdou, J.Κ., ...Stathopoulos, K., Goulis, D.G.
Hormones, 2024